For the past 40 years … there's been really no room for the idea that slow codes could be ethically permissible under any ...

Children’s Health Defense is leveraging its ties to HHS to lock in legal and cultural shifts that could shape policy long ...

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer ...

De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring animal cloning firm Viagen. The same day, ...

James Watson, the co-discoverer of the structure of DNA who died Thursday at 97, was a scientific legend and a pariah among ...

WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry ...

WASHINGTON — When President Trump announced the administration’s deal to cut prices for weight-loss drugs, he proclaimed that ...

The Trump administration announced a deal to expand access to popular obesity drugs made by Novo Nordisk and Eli Lilly ...

George Tidmarsh left the agency amid accusations of misusing his authority and after clashing with another top official.

Morning! Lots in biotech today…. New priority review vouchers from the FDA, Mark Cuban rolls out a biosimilar deal, and a ...

Six drugs were granted a “Commissioner’s National Priority Voucher” from the FDA, which guarantees speedier reviews of drug ...

After initially approving Penobscot County's request for CDC aid, the agency put it on hold. Meanwhile, the virus spreads.